Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin D Hale

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Science Advances|November 2, 2022
Multiplexed high-throughput immune cell imaging reveals molecular health-associated phenotypesYannik Severin, Benjamin D Hale, Julien Mena, et al.
Nature Cancer|April 20, 2023
Ex vivo drug response heterogeneity reveals personalized therapeutic strategies for patients with multiple myelomaKlara Kropivsek, Paul Kachel, Sandra Goetze, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2022
Multifunctional mRNA-Based CAR T Cells Display Promising Antitumor Activity Against GlioblastomaHanna Meister, Thomas Look, Patrick Roth, et al.
Science (New York, N.Y.)|June 6, 2024
Cellular architecture shapes the naïve T cell responseBenjamin D Hale, Yannik Severin, Fabienne Graebnitz, et al.
Communications Biology|February 8, 2019
Regional protein expression in human Alzheimer's brain correlates with disease severityJingshu Xu, Stefano Patassini, Nitin Rustogi, et al.
Nature Communications|October 12, 2023
Proteogenetic drug response profiling elucidates targetable vulnerabilities of myelofibrosisMattheus H E Wildschut, Julien Mena, Cyril Dördelmann, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Science Advances|November 2, 2022
Multiplexed high-throughput immune cell imaging reveals molecular health-associated phenotypesYannik Severin, Benjamin D Hale, Julien Mena, et al.
Nature Cancer|April 20, 2023
Ex vivo drug response heterogeneity reveals personalized therapeutic strategies for patients with multiple myelomaKlara Kropivsek, Paul Kachel, Sandra Goetze, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2022
Multifunctional mRNA-Based CAR T Cells Display Promising Antitumor Activity Against GlioblastomaHanna Meister, Thomas Look, Patrick Roth, et al.
Science (New York, N.Y.)|June 6, 2024
Cellular architecture shapes the naïve T cell responseBenjamin D Hale, Yannik Severin, Fabienne Graebnitz, et al.
Communications Biology|February 8, 2019
Regional protein expression in human Alzheimer's brain correlates with disease severityJingshu Xu, Stefano Patassini, Nitin Rustogi, et al.
Nature Communications|October 12, 2023
Proteogenetic drug response profiling elucidates targetable vulnerabilities of myelofibrosisMattheus H E Wildschut, Julien Mena, Cyril Dördelmann, et al.
Pageof 1